Seroprevalence of Galactomannan Aspergillus in COVID-19 patients in Jakarta: A challenge in the pandemic commotion
Article Sidebar
-
CAPA, aspergillosis, galactomannan, COVID-19
Abstract
COVID-19-associated pulmonary aspergillosis (CAPA) is a severe complication of COVID-19 due to Aspergillus infection. However, the clinical manifestation and radiology findings are not typical and require measurement of Aspergillus galactomannan (GM) level to assist in the diagnosis of CAPA. We evaluated the positivity rate of Aspergillus GM level among COVID-19 patients and investigated the correlation between the GM level and the age of patients. This retrospective observational study compiled the GM results from COVID-19 patients’ sera during the early period of the COVID-19 pandemic from March 2020 to December 2021. All samples underwent an ELISA test to measure Aspergillus GM level. There were 96 patients enrolled in this study. The positivity rate was 33%, with the highest (56%) percentage of positivity observed in the age group 40-59 in the positive Aspergillus GM group. The measurement of Aspergillus GM level among COVID-19 patients with risk factors of CAPA is critical to establish CAPA diagnosis. The availability of Aspergillus GM test in Indonesia is still limited and this issue needs to be addressed by all healthcare experts and stakeholders.
Full text article
References
Apostolopoulou, A., Garrigos, Z. E., Vijayvargiya, P., Lerner, A. H., & Farmakiotis, D. (2020). Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature. Diagnostics, 10(10), 807.
Bartoletti, M., Pascale, R., Cricca, M., Rinaldi, M., Maccaro, A., Bussini, L., Fornaro, G., Tonetti, T., Pizzilli, G., Francalanci, E., Giuntoli, L., Rubin, A., Moroni, A., Ambretti, S., Trapani, F., Vatamanu, O., Ranieri, V. M., Castelli, A., Baiocchi, M., . . . Sasdelli, G. (2020). Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clinical Infectious Diseases, 73(11), e3606–e3614.
Calderón-Parra, J., Mills-Sanchez, P., Moreno-Torres, V., Tejado-Bravo, S., Romero-Sánchez, I. M., Balandin-Moreno, B., Calvo-Salvador, M., Portero-AzorÃn, F., GarcÃa-Masedo, S., Múñez, E., Ramos, A., & Fernández-Cruz, A. (2022). COVIDâ€19â€associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVIDâ€19 patients. Mycoses, 65(5), 541–550.
Das, S., Gupta, C. M., Jain, C. P., Rai, G., Alqumber, M. A., Singh, P. K., Sharma, R.,
Tyagi, A. K., Salhotra, R., Narang, S. B., Singh, N., & Dar, S. A. (2022). Utility of serum Galactomannan in diagnosing COVID-19 patients with suspected IPA: an observational study in resource limited settings. PubMed, 26(2), 710–714.
Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., Sorrell, T. C., Bassetti, M., Akan, H., Alexander, B. D., Andes, D. R., Azoulay, E., Bialek, R., Bradsher, R. W., Bretagne, S., . . . Pappas, P. G. (2019). Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical Infectious Diseases, 71(6), 1367–1376.
Lai, C., & Yu, W. (2021). COVID-19 associated with pulmonary aspergillosis: A literature review. Journal of Microbiology Immunology and Infection, 54(1), 46-53.
Lamoth, F. (2016). Galactomannan and 1, 3-β-d-glucan testing for the diagnosis of invasive aspergillosis. Journal of Fungi, 2(3), 22.
Lamoth, F., Glampedakis, E., Boillat-Blanco, N., Oddo, M., & Pagani, J. (2020). Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clinical Microbiology and Infection, 26(12), 1706–1708.
Lass-Flörl, C., Samardzic, E., & Knoll, M. A. (2021). Serology anno 2021—fungal infections: from invasive to chronic. Clinical Microbiology and Infection, 27(9), 1230–1241.
Latgé, J., & Chamilos, G. (2019). Aspergillus fumigatus and Aspergillosis in 2019. Clinical Microbiology Reviews, 33(1).
Li, Y., & Xia, L. (2020). Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. American Journal of Roentgenology, 214(6), 1280–1286.
Kim, S., Hong, J. T., Bae, S., Lee, H., Wi, Y. M., Ko, J., Kim, B., Joo, E., Seok, H., Shi, H. J., Yoo, J. J., Hyun, M., Kim, H. A., Jang, S., Mun, S. J., Kim, J., Kim, M., Jung, D. W., Kim, S., & Peck, K. R. (2022). Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study. Journal of Korean Medical Science, 37(18).
Koehler, P., Cornely, O. A., Böttiger, B. W., Dusse, F., Eichenauer, D. A., Fuchs, F., Hallek, M., Jung, N., Klein, F., Persigehl, T., Rybniker, J., Kochanek, M., Böll, B., & Shimabukuro-Vornhagen, A. (2020). COVIDâ€19 associated pulmonary aspergillosis. Mycoses, 63(6), 528–534.
Machado, M., Valerio, M., Ãlvarez-UrÃa, A., Olmedo, M., Veintimilla, C., Padilla, B., De La Villa, S., Guinea, J., Escribano, P., Ruizâ€Serrano, M. J., Reigadas, E., Alonso, R., Guerrero, J. E., Hortal, J., Bouza, E., Muñoz, P., Alcalá, L., Aldámiz, T., Ãlvarez, B., . . . Vicente, T. (2020). Invasive pulmonary aspergillosis in the COVIDâ€19 era: An expected new entity. Mycoses, 64(2), 132–143.
Marr, K. A., Platt, A. W., Tornheim, J. A., Zhang, S. X., Datta, K., Cardozo, C., & Garcia-Vidal, C. (2021). Aspergillosis Complicating Severe Coronavirus Disease. Emerging Infectious Diseases, 27(1), 18–25.
Pintado, M. V., Camiro-Zúñiga, A., Soto, M. L., Cuenca, D., Mercado, M., Crabtree-RamÃrez, B., & Gruop, A. S. (2021). COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Medical Mycology, 59(8), 828–833.
Prattes, J., Wauters, J., Giacobbe, D. R., Salmanton-GarcÃa, J., Maertens, J., Bourgeois, M., Reynders, M., Rutsaert, L., Van Regenmortel, N., Lormans, P., Feys, S., Reisinger, A. J., Cornely, O. A., Lahmer, T., Valerio, M., Delhaes, L., Jabeen, K., Steinmann, J., Chamula, M., . . . Muñoz, P. (2022). Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology. Clinical Microbiology and Infection, 28(4), 580–587.
Rozaliyani, A., Savitri, A.I., Setianingrum, F., Shelly, T.N., Ratnasari, V., Kuswindarti, R., Salama, N., Oktavia, D., Widyastuti., Handayani, D. (2020). Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia: An Epidemiological Study. Acta Medica Indonesiana, 52(3), 246-254.
Rutsaert, L., Steinfort, N., Van Hunsel, T. J. K., Bomans, P., Naesens, R., Mertes, H., Dits, H., & Van Regenmortel, N. (2020). COVID-19-associated invasive pulmonary aspergillosis. Annals of Intensive Care, 10(1).
Thompson, G. H., Cornely, O. A., Pappas, P. G., Patterson, T. L., Hoenigl, M., Jenks, J. D., Clancy, C. J., & Nguyen, M. (2020). Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19. Open Forum Infectious Diseases, 7(7).
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R., Muñoz, P., Verweij, P. E., Warris, A., Ader, F., Akova, M., Arendrup, M. C., Barnes, R., Beigelman-Aubry, C., Blot, S., Bouza, E., Brüggemann, R. J. M., . . . Cornely, O. A. (2018). Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection, 24, e1–e38.
Authors
Copyright (c) 2023 Anna Rozaliyani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.